Chevy Chase Trust’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $11.9M | Sell |
189,601
-8,137
| -4% | -$567K | 0.03% | 370 |
|
|
2025
Q4 | $13.1M | Sell |
197,738
-2,398
| -1% | -$155K | 0.04% | 354 |
|
|
2025
Q3 | $13.5M | Sell |
200,136
-6,981
| -3% | -$552K | 0.04% | 345 |
|
|
2025
Q2 | $18.1M | Buy |
207,117
+2,204
| +1% | +$173K | 0.05% | 282 |
|
|
2025
Q1 | $14M | Sell |
204,913
-175
| -0.1% | -$14.3K | 0.04% | 323 |
|
|
2024
Q4 | $15.9M | Sell |
205,088
-9,886
| -5% | -$732K | 0.05% | 309 |
|
|
2024
Q3 | $14.4M | Sell |
214,974
-2,385
| -1% | -$196K | 0.04% | 338 |
|
|
2024
Q2 | $24.6M | Buy |
217,359
+3,773
| +2% | +$477K | 0.08% | 210 |
|
|
2024
Q1 | $29.6M | Sell |
213,586
-2,244
| -1% | -$282K | 0.1% | 185 |
|
|
2023
Q4 | $26.8M | Sell |
215,830
-2,195
| -1% | -$224K | 0.1% | 191 |
|
|
2023
Q3 | $20.3M | Sell |
218,025
-4,975
| -2% | -$561K | 0.08% | 229 |
|
|
2023
Q2 | $28.7M | Sell |
223,000
-1,553
| -0.7% | -$188K | 0.11% | 171 |
|
|
2023
Q1 | $26.1M | Buy |
224,553
+2,357
| +1% | +$264K | 0.1% | 190 |
|
|
2022
Q4 | $25.2M | Sell |
222,196
-17,549
| -7% | -$1.93M | 0.11% | 187 |
|
|
2022
Q3 | $19.3M | Buy |
239,745
+2,709
| +1% | +$229K | 0.08% | 226 |
|
|
2022
Q2 | $17.7M | Buy |
237,036
+3,940
| +2% | +$360K | 0.07% | 250 |
|
|
2022
Q1 | $29.8M | Buy |
233,096
+588
| +0.3% | +$64.3K | 0.1% | 182 |
|
|
2021
Q4 | $31.2M | Sell |
232,508
-5,100
| -2% | -$733K | 0.1% | 183 |
|
|
2021
Q3 | $32.5M | Sell |
237,608
-8,884
| -4% | -$1.12M | 0.11% | 168 |
|
|
2021
Q2 | $26.3M | Sell |
246,492
-11,700
| -5% | -$1.12M | 0.09% | 206 |
|
|
2021
Q1 | $23.2M | Sell |
258,192
-18,308
| -7% | -$1.72M | 0.08% | 230 |
|
|
2020
Q4 | $25.6M | Sell |
276,500
-7,468
| -3% | -$667K | 0.09% | 202 |
|
|
2020
Q3 | $29.3M | Sell |
283,968
-13,120
| -4% | -$1.37M | 0.12% | 167 |
|
|
2020
Q2 | $30.1M | Buy |
+297,088
| New | +$26.6M | 0.12% | 167 |
|
|
2018
Q3 | – | Sell |
-113,708
| Closed | -$2.7M | – | 675 |
|
|
2018
Q2 | $2.7M | Sell |
113,708
-69,692
| -38% | -$1.48M | 0.01% | 543 |
|
|
2018
Q1 | $3.4M | Sell |
183,400
-4,380
| -2% | -$64.8K | 0.02% | 538 |
|
|
2017
Q4 | $2.69M | Sell |
187,780
-2,560
| -1% | -$33.3K | 0.01% | 537 |
|
|
2017
Q3 | $2.33M | Buy |
190,340
+2,784
| +1% | +$49.2K | 0.01% | 540 |
|
|
2017
Q2 | $3.43M | Buy |
187,556
+17,596
| +10% | +$325K | 0.02% | 527 |
|
|
2017
Q1 | $3.6M | Buy |
+169,960
| New | +$3.32M | 0.02% | 518 |
|
Other funds holding DXCM
VCM
VPM
Chevy Chase Trust's DXCM Position: Q1 2026 in Review
Chevy Chase Trust reduced its DexCom (DXCM) stake by 4.1% in Q1 2026, selling an estimated $567K and leaving 189,601 shares worth $11.9M. The position accounts for 0.03% of the portfolio, ranked #370.
Chevy Chase Trust first reported a position in DXCM in Q1 2017 and has held it in 30 quarters since. The position peaked at $32.5M in Q3 2021. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.
- Chevy Chase Trust held 189,601 shares of DexCom worth $11.9M as of Q1 2026.
- Chevy Chase Trust sold 8,137 DexCom shares in Q1 2026, an estimated $567K.
- DexCom made up 0.03% of Chevy Chase Trust's portfolio in Q1 2026, its #370 holding.
- Chevy Chase Trust first reported a position in DexCom in Q1 2017 and has held it in 30 quarters since.
- Chevy Chase Trust's DexCom position peaked at $32.5M in Q3 2021.
- 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.
Based on Chevy Chase Trust's 13F filing for Q1 2026, filed 15 May 2026.